for Physicians
for Patients

Research Project

Project Title:

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Obinutuzumab in Patients With ISN/RPS 2003 Class III or IV Lupus Nephritis

Project Type:

 Clinical Trial, Enrolment ongoing

Disease group(s):

 Immune glomerulopathies

Project Summary:

 A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Obinutuzumab in Patients With ISN/RPS 2003 Class III or IV Lupus Nephritis.

Lead principal investigator(s):

 Dario Roccatello, Turin

Co-investigator(s):

 Daniela Rossi, Turin
Carla Naretto, Turin
Mirella Apla, Turin

Project Period:

 01/2016   -   01/2050

Sponsors:

 Industry

EudraCT Nr.:

 2015-002022-39
« Back to research page